ArticleFrontiers in oncology2021

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse.

Lijuan Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.